Amedeo Smart

Free Medical Literature Service

 

Amedeo

Chronic Renal Failure
  Free Subscription

Articles published in
Nephrol Dial Transplant
    March 2026
  1. REIS T, Cantaluppi V, Ostermann M, Brendolan A, et al
    Hemoadsorption Combined with Hemodialysis (HAHD): a Consensus Statement from an International Expert Panel.
    Nephrol Dial Transplant. 2026 Mar 3:gfag046. doi: 10.1093.
    >> Share

    February 2026
  2. ORTIZ A, Lees JS, Torra R, Stel VS, et al
    The updated global burden of chronic kidney disease: one death every 20 seconds.
    Nephrol Dial Transplant. 2026 Feb 25:gfag040. doi: 10.1093.
    >> Share

    January 2026
  3. FOUQUE D, Koppe L
    Oil supplementation and cardiovascular mortality in the dialysis population.
    Nephrol Dial Transplant. 2026 Jan 28:gfag015. doi: 10.1093.
    >> Share

  4. DEL VECCHIO L, Cases A, Eisenga MF, Malyszko J, et al
    KDIGO 2026 clinical practice guideline for Anemia in Chronic Kidney Disease (CKD): a commentary from the European Renal Best Practice (ERBP).
    Nephrol Dial Transplant. 2026 Jan 28:gfag014. doi: 10.1093.
    >> Share

  5. BOUWMANS P, Clase CM, Carrero JJ
    Drug stewardship for RAS-inhibitors and SGLT2-inhibitors in chronic kidney disease: stay on, restart.
    Nephrol Dial Transplant. 2026 Jan 22:gfag008. doi: 10.1093.
    >> Share

  6. WANG Y, Zhu L, Yang Y, You Z, et al
    Association between body roundness index and all-cause and cardiovascular disease mortality in maintenance hemodialysis patients: evidence from a prospective cohort study in Southern China.
    Nephrol Dial Transplant. 2026 Jan 21:gfag006. doi: 10.1093.
    >> Share

  7. RINCON-AREVALO H, Halleck F, Boger D, Rosenlehner E, et al
    RSVPreF3OA vaccine responses in kidney transplant recipients and dialysis patients versus healthy controls.
    Nephrol Dial Transplant. 2026 Jan 13:gfag002. doi: 10.1093.
    >> Share

    December 2025
  8. MEIJERS B, Shroff R, Battaglia Y, Kazancioglu R, et al
    Medical device regulation and dialysis practice - impact on patients, doctors and manufacturers.
    Nephrol Dial Transplant. 2025 Dec 29:gfaf269. doi: 10.1093.
    >> Share

  9. BELLIZZI V, Fordellone M, De Nicola L, Minutolo R, et al
    Cost-effectiveness of protein restricted diets in advanced CKD.
    Nephrol Dial Transplant. 2025;41:149-160.
    >> Share

  10. MAUFRAIS C, Josse M, Patrier L, Isnard M, et al
    Cardioprotection from intradialytic exercise: a randomized trial.
    Nephrol Dial Transplant. 2025;41:67-78.
    >> Share

  11. FERREIRA AC, Sezer S, Palladino G, Ortiz A, et al
    Safeguarding Innovation in Dialysis-Rethinking the EU Medical Device Regulation.
    Nephrol Dial Transplant. 2025 Dec 22:gfaf270. doi: 10.1093.
    >> Share

  12. MA LY, Tu YR, Chan MJ, Chan CI, et al
    The effect of icodextrin on peritoneal dialysis patients with congestive heart failure: a time-varying exposure design and target trial emulation approach.
    Nephrol Dial Transplant. 2025 Dec 13:gfaf265. doi: 10.1093.
    >> Share

    November 2025
  13. CASAL MOURA M, Patricio-Liebana M, Zand L, Zubidat D, et al
    Sex-specific clinical presentations and outcomes in ANCA-associated vasculitis presenting with severe kidney disease.
    Nephrol Dial Transplant. 2025;40:2359-2371.
    >> Share

  14. MIAO J, Zand J, Vaughan L, Soler MJ, et al
    Clinical phenotypes and renal outcomes in PLA2R-associated membranous nephropathy: a multi-center cohort study with unsupervised cluster analysis.
    Nephrol Dial Transplant. 2025;40:2309-2318.
    >> Share

  15. ZHANG F, Huang L, Zhong Y
    Serum sodium levels and risk of all-cause mortality among hospitalized patients with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Nov 26:gfaf255. doi: 10.1093.
    >> Share

  16. WOUDA RD, Karsten M, Michels EHA, Garrelds IM, et al
    Natriuretic Response to an Acute Oral Potassium Load in Healthy Individuals and Patients with Chronic Kidney Disease: A Randomized Controlled Trial.
    Nephrol Dial Transplant. 2025 Nov 25:gfaf238. doi: 10.1093.
    >> Share

  17. KOPYTINA V, Marchant V, Rodrigues-Diez R, Pascual-Anton L, et al
    Troxerutin is a novel osmotic agent for peritoneal dialysis with protective cardiovascular actions.
    Nephrol Dial Transplant. 2025 Nov 13:gfaf249. doi: 10.1093.
    >> Share

  18. YANG C, Liao B, Vart P, Johnson DW, et al
    Body roundness index and mortality risk in patients with chronic kidney disease: moving beyond the obesity paradox.
    Nephrol Dial Transplant. 2025 Nov 8:gfaf237. doi: 10.1093.
    >> Share

    October 2025
  19. SATISH P, Smith R, Alasadi A, Frackiewicz E, et al
    A simple test of walking speed during transplant preassessment predicts positive cardiac investigations and mortality.
    Nephrol Dial Transplant. 2025;40:2159-2168.
    >> Share

  20. SIM JJ, Chen Q, Cannizzaro N, Fernandes AW, et al
    CKD progression, kidney failure, and mortality among US patients with IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:2104-2117.
    >> Share

  21. VIRAMONTES-HORNER D, Stewart P, Stewart J, Taal MW, et al
    A novel system to continuously estimate intradialytic blood pressure in real time.
    Nephrol Dial Transplant. 2025;40:2074-2080.
    >> Share

  22. MORALES E, Jenssen TG, Bevc S, Miglinas M, et al
    Obesity as a modifiable risk factor in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Oct 30:gfaf231. doi: 10.1093.
    >> Share

  23. HEERSPINK HJL, van Raalte DH, Bjornstad P, Bunck MC, et al
    Rationale, Design, and Baseline Characteristics of the TRANSCEND-CKD trial of Retatrutide in Patients with Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Oct 29:gfaf230. doi: 10.1093.
    >> Share

  24. TIAN Z, Hillebrand UC, Casper J, Schmidt-Ott KM, et al
    Chronic kidney disease confers increased excess risks of mortality and cardiovascular events in women compared to men.
    Nephrol Dial Transplant. 2025 Oct 16:gfaf217. doi: 10.1093.
    >> Share

  25. TEOH STY, Yap DYH, Tang CSO, Chan TM, et al
    Chronic Kidney Disease G3-5 in Lupus Nephritis - Prevalence, Progression, and Risk Factors.
    Nephrol Dial Transplant. 2025 Oct 3:gfaf201. doi: 10.1093.
    >> Share

    September 2025
  26. CHUANG MH, Wang HY, Kan WC, Chien CC, et al
    Cardio-kidney outcomes for combined versus monotherapy with finerenone or SGLT2 inhibitors in patients with CKD.
    Nephrol Dial Transplant. 2025;40:1897-1905.
    >> Share

  27. ANDRE DE LA RAMBELJE M, Beldhuis IE, Heerspink HJL, Greasley PJ, et al
    Protein profiles and associated biological pathways among different etiologies of chronic kidney disease: new insights from DAPA-CKD.
    Nephrol Dial Transplant. 2025 Sep 8:gfaf180. doi: 10.1093.
    >> Share

    August 2025
  28. SLON-ROBLERO MF, Stel VS, Sanchez-Alvarez E, Escola JM, et al
    Trends in Home Dialysis Over the Last Decade in Europe: an ERA Registry Study.
    Nephrol Dial Transplant. 2025 Aug 29:gfaf171. doi: 10.1093.
    >> Share

  29. ATIQUZZAMAN M, Er L, Djurdjev O, Zheng Y, et al
    COVID-19 infection and the progression of kidney disease in British Columbia, Canada.
    Nephrol Dial Transplant. 2025;40:1717-1726.
    >> Share

  30. CASINO FG, Casino A, Herva ET, Basile C, et al
    New formulas for calculating dialysis dose in incremental haemodialysis.
    Nephrol Dial Transplant. 2025 Aug 7:gfaf147. doi: 10.1093.
    >> Share

  31. BATTAGLIA Y, Shroff R, Meijers B, Nistor I, et al
    Haemodiafiltration versus high-flux haemodialysis-a Consensus Statement from the EuDial Working Group of the ERA.
    Nephrol Dial Transplant. 2025;40:1590-1614.
    >> Share

  32. YAO YX, Tang C, Shi SF, Chen P, et al
    Red blood cell casts on kidney biopsy and progression of IgA nephropathy.
    Nephrol Dial Transplant. 2025;40:1570-1579.
    >> Share

  33. YOSHIDA M, Maeoka Y, Takahashi A, Ishiuchi N, et al
    Effect of haemodiafiltration versus haemodialysis on vascular access patency when starting haemodialysis.
    Nephrol Dial Transplant. 2025;40:1538-1549.
    >> Share

  34. PAGNIEZ MS, Fages V, Gatinois C, Larrue R, et al
    Exon location of glycine substitutions impacts kidney survival in autosomal dominant Alport syndrome.
    Nephrol Dial Transplant. 2025;40:1522-1530.
    >> Share

    July 2025
  35. PERIS-FERNANDEZ M, Roca-Marugan MI, Viejo-Boyano I, Soldevila-Orient A, et al
    Hemodialysis removes protective metabolites and disrupts mitochondrial function.
    Nephrol Dial Transplant. 2025 Jul 31:gfaf145. doi: 10.1093.
    >> Share

  36. ZOCCALI C, Chinnappa S, Fernandez-Fernandez B, Iatridi F, et al
    Myocardial Ischaemic Syndromes in Chronic Kidney Disease: Risky Pathways from Non-Acute to Acute Events.
    Nephrol Dial Transplant. 2025 Jul 30:gfaf142. doi: 10.1093.
    >> Share

  37. AOUN M, Combe C, Jadoul M
    Life Support in Hemodialysis Emergencies - Treatment standard.
    Nephrol Dial Transplant. 2025 Jul 15:gfaf136. doi: 10.1093.
    >> Share

  38. COX EF, Gullapudi VRL, Buchanan CE, White K, et al
    Effect of haemodialysis on the brain and heart assessed using multiparametric MRI.
    Nephrol Dial Transplant. 2025 Jul 9:gfaf117. doi: 10.1093.
    >> Share

  39. BONIFANT G, Davis SN, Weir MR
    Treatment of diabetes in patients with advanced chronic kidney disease or kidney failure.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf083. doi: 10.1093.
    >> Share

  40. LAVILLE SM, Mouheb A, Massy ZA, Jacquelinet C, et al
    Male and female drug prescription patterns and adverse drug reactions in chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf125. doi: 10.1093.
    >> Share

  41. GUERRA JMA, Martinez-Martinez JI
    Multifactorial chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 4:gfaf122. doi: 10.1093.
    >> Share

  42. CHERNEY DZI, Belmar N, Bjornstad P, Chacko MM, et al
    Rationale, design and baseline characteristics of REMODEL, a mechanism-of-action trial with semaglutide in people with type 2 diabetes and chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jul 3:gfaf114. doi: 10.1093.
    >> Share

    June 2025
  43. MARENGO M, Migliori M, Merlotti G, Naso E, et al
    High-flux hemodialysis with polymethylmethacrylate membranes reduces soluble CD40L, a mediator of cardiovascular disease in uremia.
    Nephrol Dial Transplant. 2025 Jun 6:gfaf101. doi: 10.1093.
    >> Share


  44. Correction to: Upcoming drug targets for kidney protective effects in chronic kidney disease.
    Nephrol Dial Transplant. 2025 Jun 5:gfaf099. doi: 10.1093.
    >> Share

  45. HALBRITTER J, Figueres L, Van Eerde AM, Capasso G, et al
    Chronic Kidney Disease of unexplained cause (CKDx): a consensus statement by the Genes & Kidney Working Group of the ERA.
    Nephrol Dial Transplant. 2025 Jun 3:gfaf092. doi: 10.1093.
    >> Share

    May 2025
  46. WANG Z, Xiang W, Wang Y, Yu J, et al
    Patients with membranous lupus nephritis form two clusters with different prognoses.
    Nephrol Dial Transplant. 2025;40:1213-1224.
    >> Share

  47. SHEN X, Chen P, Liu M, Liu L, et al
    Long-term outcomes of IgA nephropathy in China.
    Nephrol Dial Transplant. 2025;40:1137-1146.
    >> Share

  48. MORALES E, Martin WP, Bevc S, Jenssen TG, et al
    How to individualise renoprotective therapy in obese patients with chronic kidney disease: a commentary by the Diabesity Working Group of the ERA.
    Nephrol Dial Transplant. 2025 May 13:gfaf069. doi: 10.1093.
    >> Share

  49. ZOCCALI C, Lameire N, Ronco C, Carlson N, et al
    Acute kidney injury, acute kidney disease, and chronic kidney disease: challenges and research perspectives.
    Nephrol Dial Transplant. 2025 May 12:gfaf090. doi: 10.1093.
    >> Share

  50. GLASSOCK RJ, Rule AD, Denic A, Delanaye P, et al
    KIDNEY AGING and CHRONIC KIDNEY DISEASE - Another Perspective.
    Nephrol Dial Transplant. 2025 May 7:gfaf087. doi: 10.1093.
    >> Share


  51. Correction to: Global health inequalities of chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2025 May 6:gfaf080. doi: 10.1093.
    >> Share

    April 2025
  52. QUENNEPOIX M, Koppe L, Bevier A, Barba C, et al
    Comparison of different heparin-free dialysis methods.
    Nephrol Dial Transplant. 2025 Apr 30:gfaf082. doi: 10.1093.
    >> Share

  53. SCHMIDT-LAUBER C, Thompson C, Schmidt EA, Klopp A, et al
    Prevalence and Characteristics of Chronic Kidney Disease in the Hamburg City Health Study.
    Nephrol Dial Transplant. 2025 Apr 30:gfaf075. doi: 10.1093.
    >> Share

  54. HAUPENTHAL F, Doberer K, Kapps S, Klager J, et al
    Self-reported Non-adherence to Immunosuppressive Medication Detected by the BAASIS Predicts Allograft Rejections in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 28:gfaf078. doi: 10.1093.
    >> Share

  55. YEPES-CALDERON M, Martin Del Campo Sanchez F, Kremer D, Knobbe TJ, et al
    Plasma Trimethylamine N-oxide Concentration and All-Cause Mortality in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2025 Apr 24:gfaf071. doi: 10.1093.
    >> Share

  56. DOLAN KJ, Gist KM, Basalely A, Bottari G, et al
    Functional outcomes in pediatric patients on renal replacement therapy in a worldwide registry.
    Nephrol Dial Transplant. 2025 Apr 21:gfaf067. doi: 10.1093.
    >> Share

  57. KANBAY M, Abdel-Rahman SM, Brinza C, Ozbek L, et al
    A Meta-analysis of Graft Survival, Patient Survival, and Delayed Graft Function in First-Time and Repeat Kidney Transplants.
    Nephrol Dial Transplant. 2025 Apr 15:gfaf066. doi: 10.1093.
    >> Share

  58. MONTEZ DE SOUSA IR, Bonthuis M, Kramer A, Ordonez FA, et al
    Adult outcomes of childhood kidney replacement therapy in Europe from 2008 to 2019: an ERA Registry study.
    Nephrol Dial Transplant. 2025;40:707-719.
    >> Share

    March 2025
  59. AGRAWAL R, Waller JL, Baer SL, Bollag WB, et al
    Psoriaisis associates with increased risk for kidney transplant rejection.
    Nephrol Dial Transplant. 2025 Mar 26:gfaf047. doi: 10.1093.
    >> Share

  60. ZHAO Y, Yang K, Nguyen CM, Wu H, et al
    Sex-specific cardiac dysfunction in mice with chronic kidney disease.
    Nephrol Dial Transplant. 2025 Mar 21:gfaf056. doi: 10.1093.
    >> Share

  61. FERRO CJ, Wanner C, Luyckx V, Stevens K, et al
    ABCDE to identify and prevent chronic kidney disease: a call to action.
    Nephrol Dial Transplant. 2025 Mar 19:gfaf057. doi: 10.1093.
    >> Share

  62. ANDRADE A, Bachmann M, Bobot M, Bruchfeld A, et al
    Cognitive impairment in chronic kidney disease: role of brain imaging, functional imaging, electroencephalography, cerebrospinal fluid biomarkers and sensors.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  63. PEPIN M, Giannakou K, Levassort H, Farinha A, et al
    Care pathways for patients with cognitive impairment and chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  64. ZHANG Y, Ye Z, Zhang Y, Yang S, et al
    Dietary vitamin E and tocopherol isoform intake and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2025 Mar 7:gfaf052. doi: 10.1093.
    >> Share

  65. BAKKER WM, Heerspink HJL, Berger SP, Wanner C, et al
    Rationale and design of the Renal Lifecycle Trial assessing the Effect of Dapagliflozin on Cardiorenal Outcomes in Severe Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Mar 7:gfaf046. doi: 10.1093.
    >> Share

    February 2025
  66. URO-COSTE C, Lambert C, Audard V, Couzi L, et al
    Prophylactic treatment of FSGS recurrence in patients who relapsed on a previous kidney graft.
    Nephrol Dial Transplant. 2025;40:475-483.
    >> Share

  67. PREKA E, Bonthuis M, Marks SD, Kramer A, et al
    Access to kidney transplantation and re-transplantation from childhood to adulthood: long-term data from the ERA Registry.
    Nephrol Dial Transplant. 2025 Feb 12:gfaf025. doi: 10.1093.
    >> Share

  68. KANDURI SR, Badari A, Ullah F, Yang CW, et al
    Recovery from acute kidney injury treated with dialysis in patients with multiple myeloma treated with proteasome inhibitors.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf028. doi: 10.1093.
    >> Share

  69. XU H, Eriksdotter M, Hafez G, Mitra S, et al
    Cholinergic system in patients with chronic kidney disease: cognitive and renal implications.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf029. doi: 10.1093.
    >> Share

  70. AGARWAL R, Green JB, Heerspink HJL, Mann JFE, et al
    COmbinatioN effect of FInerenone anD EmpaglifloziN in participants with chronic kidney disease and type 2 diabetes using a UACR Endpoint (CONFIDENCE) trial: Baseline clinical characteristics.
    Nephrol Dial Transplant. 2025 Feb 7:gfaf022. doi: 10.1093.
    >> Share

  71. WAGNER CA
    Beyond SGLT2: proximal tubule transporters as potential drug targets for chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  72. ALICIC RZ, Neumiller JJ, Tuttle KR
    Combination therapy: an upcoming paradigm to improve kidney and cardiovascular outcomes in chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  73. NEUEN BL, Yeung EK, Rangaswami J, Vaduganathan M, et al
    Combination therapy as a new standard of care in diabetic and non-diabetic chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  74. ZHU D, Judge PK, Staplin N, Haynes R, et al
    Design considerations for future renoprotection trials in the era of multiple therapies for chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  75. NARDONE M, Yau K, Kugathasan L, Odutayo A, et al
    Upcoming drug targets for kidney protective effects in chronic kidney disease.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  76. MOEDT E, Wasehuus VS, Heerspink HJL
    Selective endothelin A receptor antagonism in chronic kidney disease: improving clinical application.
    Nephrol Dial Transplant. 2025;40.
    >> Share

  77. CHEIKH HASSAN H, Tunnicliffe DJ, Loyd L, Mullan A, et al
    Kidney failure from kidney stones: an ANZDATA study.
    Nephrol Dial Transplant. 2025;40:320-328.
    >> Share

    January 2025
  78. JORGENSEN HS, Vervloet M, Cavalier E, Bacchetta J, et al
    The role of nutritional vitamin D in CKD-MBD in children and adults with CKD, on dialysis and after kidney transplantation - a European consensus statement.
    Nephrol Dial Transplant. 2025 Jan 28:gfae293. doi: 10.1093.
    >> Share

  79. TORINO C, Mallamaci F, Tripepi R, Mezzatesta S, et al
    The use of lung-ultrasound monitoring and the risk of intradialysis hypotension in hemodialysis patients: an analysis in the context of a randomized clinical trial.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf015. doi: 10.1093.
    >> Share

  80. ZOCCALI C, Mallamaci F, Kanbay M, Tuttle KR, et al
    The Autonomic Nervous System and Inflammation in Chronic Kidney Disease.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf020. doi: 10.1093.
    >> Share

  81. YEN FS, Wei JC, Cheng WY, Huang CT, et al
    Low birth weight and chronic kidney disease with progression to kidney failure in children.
    Nephrol Dial Transplant. 2025 Jan 27:gfaf018. doi: 10.1093.
    >> Share

    December 2024
  82. FRIEDRICH J, Bellmann M, Klank D, Porubsky S, et al
    Clinical and histological comparison of IgA nephritis and renal IgA vasculitis.
    Nephrol Dial Transplant. 2024;40:182-192.
    >> Share

  83. BUTZ E, Schultheiss UT, Sekula P
    Modeling heterogeneity in the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Dec 19:gfae288. doi: 10.1093.
    >> Share

  84. GANSEVOORT RT, Wheeler DC, Deben FM, Speeckaert M, et al
    The soluble guanylate cyclase activator runcaciguat significantly improves albuminuria in patients with chronic kidney disease: a randomized placebo-controlled clinical trial.
    Nephrol Dial Transplant. 2024 Dec 3:gfae261. doi: 10.1093.
    >> Share

    November 2024
  85. AKIFOVA A, Budde K, Amann K, Buettner-Herold M, et al
    Donor-derived cell-free DNA monitoring for early diagnosis of antibody-mediated rejection after kidney transplantation: a randomized trial.
    Nephrol Dial Transplant. 2024 Nov 29:gfae282. doi: 10.1093.
    >> Share

  86. HAHN LUNDSTROM U, Ramspek CL, Dekker FW, van Diepen M, et al
    Clinical impact of the Kidney Failure Risk Equation for vascular access planning.
    Nephrol Dial Transplant. 2024;39:2079-2087.
    >> Share

  87. SUENAGA T, Tanaka S, Kitamura H, Tsuruya K, et al
    Estimated potassium intake and the progression of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 27:gfae277. doi: 10.1093.
    >> Share

  88. DASGUPTA I, Meadowcroft AM, Bhatt PR, Acharya A, et al
    Efficacy and safety of daprodustat in patients on peritoneal dialysis in the ASCEND-D trial.
    Nephrol Dial Transplant. 2024 Nov 21:gfae273. doi: 10.1093.
    >> Share

  89. DIETER RA, Mattoo A, Hotchkis P, Jaffe IS, et al
    Prophylactic 2-week Glecaprevir/Pibrentasvir in Hepatitis C positive to negative kidney transplantation.
    Nephrol Dial Transplant. 2024 Nov 20:gfae271. doi: 10.1093.
    >> Share

  90. DE HAAN A, Eijgelsheim M, Vogt L, Hoorn EJ, et al
    Genetic testing in a national cohort of adults with chronic kidney disease of unknown origin.
    Nephrol Dial Transplant. 2024 Nov 19:gfae270. doi: 10.1093.
    >> Share

  91. JOO YS, Yun HR, Kim HW, Koh HB, et al
    Smoking cessation and atherosclerotic cardiovascular events and mortality in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 15:gfae268. doi: 10.1093.
    >> Share

  92. JUDGE PK, Tuttle KR, Staplin N, Hauske SJ, et al
    The potential for improving cardio-renal outcomes in chronic kidney disease with the aldosterone synthase inhibitor vicadrostat (BI 690517): a rationale for the EASi-KIDNEY trial.
    Nephrol Dial Transplant. 2024 Nov 12:gfae263. doi: 10.1093.
    >> Share

  93. METSARINNE K, Bodegard J, Toppila I, Uusi-Rauva K, et al
    Characteristics, treatment and disease burden among stage 3-4 chronic kidney disease patients with and without type 2 diabetes in Finland during 2016-2022.
    Nephrol Dial Transplant. 2024 Nov 7:gfae242. doi: 10.1093.
    >> Share

  94. ZIMMERMANN S, Mathew A, Bondareva O, Elwakiel A, et al
    Noncanonical microglial IL-1beta maturation in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Nov 4:gfae239. doi: 10.1093.
    >> Share

    October 2024
  95. KRAMER A, Jager KJ, Chesnaye NC, Kerschbaum J, et al
    Changes in the epidemiology of kidney replacement therapy across Europe in 2020-the first year of the COVID-19 pandemic: an ERA Registry study.
    Nephrol Dial Transplant. 2024;39:1835-1845.
    >> Share

  96. NG MSY, Jones AT, Mallett AJ, O'Shaughnessy MM, et al
    Better kidney allograft survival despite higher-risk donor and recipient characteristics between 1995 and 2014.
    Nephrol Dial Transplant. 2024;39:1846-1855.
    >> Share

  97. HAMROUN A, Aymes E, Couchoud C, Bechade C, et al
    Elderly predialysis care pathways and early morbidity-mortality upon start of dialysis.
    Nephrol Dial Transplant. 2024 Oct 18:gfae236. doi: 10.1093.
    >> Share

  98. DUARTE MP, Nobrega OT, Vogt BP, Pereira MS, et al
    Reference Values for Handgrip Strength, Five Times Sit-to-stand, and Gait Speed in Patients on Hemodialysis.
    Nephrol Dial Transplant. 2024 Oct 16:gfae232. doi: 10.1093.
    >> Share

  99. COHEN EP, Denic A, Aperna F, Mullan AF, et al
    Stenosis of the glomerulotubular neck in progressive chronic kidney disease.
    Nephrol Dial Transplant. 2024 Oct 16:gfae234. doi: 10.1093.
    >> Share

  100. WAGNER CA, Massy ZA, Capasso G, Mattace-Raso F, et al
    Translational research on cognitive impairment in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Oct 14:gfae229. doi: 10.1093.
    >> Share

  101. ARDAVANI A, Curtis F, Hopwood E, Highton P, et al
    Effect of pharmacist interventions in chronic kidney disease: a meta-analysis.
    Nephrol Dial Transplant. 2024 Oct 9:gfae221. doi: 10.1093.
    >> Share

  102. AN S, Qian H, Yang J, Han C, et al
    Cardiac magnetic resonance assessment of cardiac function across chronic kidney disease stages.
    Nephrol Dial Transplant. 2024 Oct 4:gfae222. doi: 10.1093.
    >> Share

    September 2024
  103. BAE S, Chen Y, Sandal S, Lentine KL, et al
    Association of early steroid withdrawal with kidney transplant outcomes in first-transplant and retransplant recipients.
    Nephrol Dial Transplant. 2024 Sep 30:gfae218. doi: 10.1093.
    >> Share

  104. ZHUANG B, Gan L, Liu B, Yuan W, et al
    Tolerability, safety and efficacy of a novel phosphate binder VS-505 (AP301): a Phase 2 dose-escalation and dose-ranging study in patients undergoing maintenance hemodialysis.
    Nephrol Dial Transplant. 2024;39:1649-1661.
    >> Share

  105. STEL VS, Boenink R, Astley ME, Boerstra BA, et al
    A comparison of the epidemiology of kidney replacement therapy between Europe and the United States: 2021 data of the ERA Registry and the USRDS.
    Nephrol Dial Transplant. 2024;39:1593-1603.
    >> Share

  106. OLIVERAS L, Rosales BM, De La Mata N, Vajdic CM, et al
    Relative survival in patients with cancer and kidney failure.
    Nephrol Dial Transplant. 2024;39:1604-1612.
    >> Share

  107. IATRIDI F, Carrero JJ, Gall EC, Kanbay M, et al
    A commentary from the European Renal Best Practice (ERBP) on the Kidney Disease Improving Global Outcomes (KDIGO) 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease in children and adults.
    Nephrol Dial Transplant. 2024 Sep 19:gfae209. doi: 10.1093.
    >> Share

  108. MAYNE KJ, Sardell RJ, Staplin N, Judge PK, et al
    Empagliflozin lowers serum uric acid in chronic kidney disease: exploratory analyses from the EMPA-KIDNEY trial.
    Nephrol Dial Transplant. 2024 Sep 14:gfae203. doi: 10.1093.
    >> Share

  109. MAHBOOBI S, Mollard R, Tangri N, Askin N, et al
    Effects of dietary interventions for metabolic acidosis in chronic kidney disease: a systematic review and meta-analysis.
    Nephrol Dial Transplant. 2024 Sep 14:gfae200. doi: 10.1093.
    >> Share

  110. ARANA C, Hermida E, Rovira J, Caro JL, et al
    Antibody-mediated rejection diagnosed in early protocol biopsies in high immunological risk kidney transplant recipients.
    Nephrol Dial Transplant. 2024 Sep 10:gfae186. doi: 10.1093.
    >> Share

  111. VANHOLDER R, Bach D, Davies S, Finne P, et al
    Proactively boosting home dialysis adoption in Europe.
    Nephrol Dial Transplant. 2024 Sep 9:gfae199. doi: 10.1093.
    >> Share

  112. CHO Y, Cullis B, Ethier I, Htay H, et al
    Global structures, practices, and tools for provision of chronic peritoneal dialysis.
    Nephrol Dial Transplant. 2024;39.
    >> Share

  113. HTAY H, Cho Y, Jha V, See E, et al
    Global structures, practices, and tools for provision of hemodialysis.
    Nephrol Dial Transplant. 2024;39.
    >> Share

  114. VIECELLI AK, Gately R, Barday Z, Shojai S, et al
    Worldwide organization and structures for kidney transplantation services.
    Nephrol Dial Transplant. 2024;39.
    >> Share

    August 2024
  115. ZHANG LY, Dinh A, Johansen KL, McCulloch CE, et al
    Access to kidney transplantation from dialysis facilities affiliated with a transplant center versus free-standing dialysis facilities in the US.
    Nephrol Dial Transplant. 2024 Aug 30:gfae194. doi: 10.1093.
    >> Share

  116. ALUND O, Unwin R, Challis B, Kalra PA, et al
    A note on performance metrics for the Kidney Failure Risk Equation.
    Nephrol Dial Transplant. 2024;39:1523-1525.
    >> Share

  117. SACHEZ-ALAMO B, Moi L, Bajema I, Berden A, et al
    Long-term outcome of kidney function in patients with ANCA-associated vasculitis.
    Nephrol Dial Transplant. 2024;39:1483-1493.
    >> Share

  118. QUIROGA B, Diez J
    The kidney-skeletal muscle-heart axis in chronic kidney disease: implications for myokines.
    Nephrol Dial Transplant. 2024 Aug 30:gfae193. doi: 10.1093.
    >> Share

  119. PANIAGUA R, Ramos A, Avila M, Ventura MD, et al
    Remote monitoring of automated peritoneal dialysis reduces mortality, adverse events, and hospitalizations: a cluster randomized controlled trial.
    Nephrol Dial Transplant. 2024 Aug 20:gfae188. doi: 10.1093.
    >> Share

  120. SCHROPPEL B, Bettac L, Schulte-Kemna L, Kachele M, et al
    Placement of tunneled hemodialysis catheters - interventional standard.
    Nephrol Dial Transplant. 2024 Aug 16:gfae181. doi: 10.1093.
    >> Share

  121. GROSS O, Boeckhaus J, Weber LT, Heerspink HJL, et al
    Protocol and rationale for a randomized controlled SGLT2 inhibitor trial in pediatric and young adult populations with chronic kidney disease: DOUBLE PRO-TECT Alport.
    Nephrol Dial Transplant. 2024 Aug 9:gfae180. doi: 10.1093.
    >> Share

    July 2024
  122. DONG Y, Wang Z, Guo W, Zhu L, et al
    Association between urinary C4d levels and disease progression in IgA nephropathy.
    Nephrol Dial Transplant. 2024;39:1279-1287.
    >> Share

  123. KOMMER A, Kostev K, Schleicher EM, Weinmann-Menke J, et al
    Proton pump inhibitor use and bone fractures in patients with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jul 18:gfae135. doi: 10.1093.
    >> Share

  124. LI Z, Chen S, Tan Y, Lv J, et al
    The effect of preeclampsia on long-term kidney function among pregnant women with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Jul 17:gfae172. doi: 10.1093.
    >> Share

  125. MAKHLOUFI M, Cottinet PJ, Ranchin B, Dureuil B, et al
    Hemodialysis versus peritoneal dialysis in children: an eco-audit.
    Nephrol Dial Transplant. 2024 Jul 13:gfae159. doi: 10.1093.
    >> Share

  126. COLLISTER D, Pyne L, Bhasin AA, Smyth B, et al
    Heart failure events in randomized controlled trials for adults receiving maintenance dialysis: a meta-epidemiologic study.
    Nephrol Dial Transplant. 2024 Jul 10:gfae156. doi: 10.1093.
    >> Share

  127. FAGUER S, Serre JE, Brusq C, Bongard V, et al
    A randomized crossover trial of regional anticoagulation modalities for intermittent hemodialysis.
    Nephrol Dial Transplant. 2024 Jul 8:gfae155. doi: 10.1093.
    >> Share

  128. GHIMIRE A, Lloyd AM, Bello AK, Battistella M, et al
    Prescribing patterns and medications costs in patients on maintenance hemodialysis and peritoneal dialysis.
    Nephrol Dial Transplant. 2024 Jul 4:gfae154. doi: 10.1093.
    >> Share

    June 2024
  129. BOGATAJ S, Roelands B, Pajek M, Pajek J, et al
    Intradialytic cycling and cognitive training to mitigate decreased functional and physiological status in haemodialysis patients.
    Nephrol Dial Transplant. 2024;39:1198-1200.
    >> Share

  130. KIM JE, Park J, Jang Y, Kang E, et al
    Oral phosphate binders and incident osteoporotic fracture in patients on dialysis.
    Nephrol Dial Transplant. 2024 Jun 17:gfae139. doi: 10.1093.
    >> Share

  131. HEERSPINK HJL, Agarwal R, Bakris GL, Cherney DZI, et al
    Design and baseline characteristics of the Finerenone, in addition to standard of care, on the progression of kidney disease in patients with Non-Diabetic Chronic Kidney Disease (FIND-CKD) randomized trial.
    Nephrol Dial Transplant. 2024 Jun 11:gfae132. doi: 10.1093.
    >> Share

    May 2024
  132. BATTAGLIA Y, Mantovani A, Shroff R, Alfano G, et al
    Online haemodiafiltration and all-cause mortality: how fragile are the results of the studies published so far?
    Nephrol Dial Transplant. 2024;39:1034-1036.
    >> Share

  133. LABRIOLA L, Crott R, Desmet C, Romain C, et al
    Infectious complications associated with buttonhole cannulation of native arteriovenous fistulas: a 22-year follow-up.
    Nephrol Dial Transplant. 2024;39:1000-1007.
    >> Share

  134. CORTE-IGLESIAS V, Saiz ML, Andrade-Lopez AC, Salazar N, et al
    Propionate and butyrate counteract renal damage and progression to chronic kidney disease.
    Nephrol Dial Transplant. 2024 May 24:gfae118. doi: 10.1093.
    >> Share

  135. VANHOLDER R, Bach D, Davies S, Finne P, et al
    Unlocking the Untapped Potential: The Neglected Home Dialysis Assets in Europe.
    Nephrol Dial Transplant. 2024 May 16:gfae111. doi: 10.1093.
    >> Share

  136. KREMER D, Salamah S, Groothof D, Post A, et al
    Plasma Symmetric Dimethylarginine and Kidney Graft Function in Kidney Transplant Recipients.
    Nephrol Dial Transplant. 2024 May 15:gfae109. doi: 10.1093.
    >> Share

  137. MCEWAN P, Gabb PD, Davis JA, Sanchez JJG, et al
    The long-term effects of dapagliflozin in chronic kidney disease: a time-to-event analysis.
    Nephrol Dial Transplant. 2024 May 10:gfae106. doi: 10.1093.
    >> Share

  138. KRAMER A, Boenink R, Mercado Vergara CG, Bell S, et al
    Time trends in preemptive kidney transplantation in Europe: an era registry study.
    Nephrol Dial Transplant. 2024 May 9:gfae105. doi: 10.1093.
    >> Share

  139. IATRIDI F, Malandris K, Ekart R, Xagas E, et al
    Low dialysate sodium and 48-h ambulatory blood pressure in patients with intradialytic hypertension: a randomized crossover study.
    Nephrol Dial Transplant. 2024 May 6:gfae104. doi: 10.1093.
    >> Share

    April 2024
  140. WOLFGRAM DF, Richerson WT, Murray AM, Schmit BD, et al
    Cognitive deficits associate with cerebral hypoxia during hemodialysis.
    Nephrol Dial Transplant. 2024 Apr 30:gfae101. doi: 10.1093.
    >> Share

  141. LEMOINE S, Akbari A, Brahm G, Dorie J, et al
    Redefining the concept of residual renal function with kidney sodium MRI: a pilot study.
    Nephrol Dial Transplant. 2024 Apr 30:gfae070. doi: 10.1093.
    >> Share

  142. KANBAY M, Basile C, Battaglia Y, Mantovani A, et al
    Shared decision making in elderly patients with kidney failure.
    Nephrol Dial Transplant. 2024;39:742-751.
    >> Share

  143. LIAO YR, Tsai YC, Hsieh TH, Tsai MT, et al
    FHL2 in arterial medial calcification in chronic kidney disease.
    Nephrol Dial Transplant. 2024 Apr 25:gfae091. doi: 10.1093.
    >> Share

  144. LOMBARDI G, Ferraro PM, De Tomi E, Bargagli M, et al
    Sex differences in chronic kidney disease-related complications and mortality across levels of glomerular filtration rate.
    Nephrol Dial Transplant. 2024 Apr 17:gfae087. doi: 10.1093.
    >> Share

  145. ZHANG X, Wang G, Li M, Li Y, et al
    Both partial inactivation as well as activation of NF-kappaB signaling lead to hypertension and chronic kidney disease.
    Nephrol Dial Transplant. 2024 Apr 13:gfae090. doi: 10.1093.
    >> Share


  146. Correction to: Associations of neutral pH, low-GDP peritoneal dialysis solutions with patient survival, transfer to haemodialysis and peritonitis.
    Nephrol Dial Transplant. 2024 Apr 10:gfae073. doi: 10.1093.
    >> Share

  147. STOUMPOS S, Crowe K, Sarafidis P, Barratt J, et al
    Hypoxia-inducible factor prolyl hydroxylase inhibitors for anaemia in chronic kidney disease: a document by the European Renal Best Practice board of the European Renal Association.
    Nephrol Dial Transplant. 2024 Apr 4:gfae075. doi: 10.1093.
    >> Share

    March 2024
  148. ELEFTHERIADIS G, Naik MG, Osmanodja B, Halleck F, et al
    Office or home versus 24-hour blood pressure measurement in stable kidney transplant recipients.
    Nephrol Dial Transplant. 2024 Mar 28:gfae076. doi: 10.1093.
    >> Share

  149. WINDAHL K, Chesnaye NC, Irving GF, Stenvinkel P, et al
    The safety of a low protein diet in older adults with advanced chronic kidney disease.
    Nephrol Dial Transplant. 2024 Mar 27:gfae077. doi: 10.1093.
    >> Share

  150. FORBES AK, Hinton W, Feher MD, Elson W, et al
    A Comparison of Sodium-Glucose Co-Transporter 2 Inhibitor Kidney Outcome Trial Participants with a Real-World Chronic Kidney Disease Primary Care Population.
    Nephrol Dial Transplant. 2024 Mar 22:gfae071. doi: 10.1093.
    >> Share

  151. VALENZUELA PL, Castillo-Garcia A, Saco-Ledo G, Santos-Lozano A, et al
    Physical exercise: a polypill against chronic kidney disease.
    Nephrol Dial Transplant. 2024 Mar 9:gfae062. doi: 10.1093.
    >> Share

  152. ZHAI S, Liu D, Liu H, Li W, et al
    Cold atmospheric plasma for chronic kidney disease-related skin disorders.
    Nephrol Dial Transplant. 2024 Mar 1:gfae057. doi: 10.1093.
    >> Share

    February 2024
  153. VAN OEVELEN M, Bonenkamp AA, van Eck van der Sluijs A, Bos WJW, et al
    Health-related quality of life and symptom burden in patients on haemodialysis.
    Nephrol Dial Transplant. 2024;39:436-444.
    >> Share

  154. AKERBOOM B, Janse RJ, Caldinelli A, Lindholm B, et al
    A tool to predict the risk of lower extremity amputation in patients starting dialysis.
    Nephrol Dial Transplant. 2024 Feb 26:gfae050. doi: 10.1093.
    >> Share

  155. KUNUTSOR SK, Dey RS, Touw DJ, Bakker SJL, et al
    Urine cotinine versus self-reported smoking and the risk of chronic kidney disease.
    Nephrol Dial Transplant. 2024 Feb 24:gfae054. doi: 10.1093.
    >> Share

  156. VERZOLA D, Saio M, Milanesi S, Picciotto D, et al
    Altered adiponectin regulation in skeletal muscle of patients with chronic kidney disease.
    Nephrol Dial Transplant. 2024 Feb 23:gfae051. doi: 10.1093.
    >> Share

  157. ADOLI LK, Couchoud C, Chatelet V, Lobbedez T, et al
    Lower access to kidney transplantation for women in France is not explained by comorbidities and social deprivation.
    Nephrol Dial Transplant. 2024 Feb 21:gfae047. doi: 10.1093.
    >> Share

    November 2023
  158. DE LA MATA NL, Khou V, Hedley JA, Kelly PJ, et al
    Journey to kidney transplantation: patient dynamics, suspensions, transplantation and deaths in the Australian kidney transplant waitlist.
    Nephrol Dial Transplant. 2023 Nov 28:gfad253. doi: 10.1093.
    >> Share

  159. HARDING JL, Di M, Pastan SO, Doucet N, et al
    Examination of Sex/Gender Disparities Across the Continuum of Kidney Transplant Steps.
    Nephrol Dial Transplant. 2023 Nov 9:gfad242. doi: 10.1093.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016